Navigation Links
Black Breast Cancer Survivors Face Higher Heart Failure Risk: Study
Date:3/7/2013

THURSDAY, March 7 (HealthDay News) -- Black breast cancer survivors seem more likely to develop heart failure than other women, a new study says.

Researchers analyzed data from more than 26,000 U.S. women who were diagnosed with breast cancer between 1973 and 2007 and survived. More than three-quarters were 65 or older.

Of these women, 16 percent later developed heart failure. The rate of heart failure was 21 percent among black women, 16 percent among whites, 13 percent among Hispanics, 12 percent among Asians and 11 percent among others, including Native Americans.

Heart failure occurs when the heart can no longer pump enough blood to the rest of the body. About half of people with heart failure die within five years after diagnosis, according to the U.S. Centers for Disease Control and Prevention.

According to the study, black breast cancer survivors had a 1.4-fold greater risk of heart failure than white survivors, although both had the same risk of dying after developing heart failure. The study is scheduled for presentation Thursday at the American College of Cardiology's annual scientific meeting in San Francisco.

The increased risk among black women remained even after the researchers accounted for other factors, including age, high blood pressure, diabetes and the use of chemotherapy drugs or medicines to protect the heart -- called cardioprotective drugs.

The findings could prove important for the nearly 27,000 new cases of breast cancer diagnosed in black women each year, the researchers said.

"In general, African-American women are more susceptible to heart problems as they are disproportionately affected by high blood pressure, obesity, diabetes, high oxidative stress and even vitamin D deficiency," study lead investigator Dr. Anna Valina-Toth, a second-year internal medicine resident at Case Western Reserve University, in Cleveland, said in a university news release. "Our findings suggest that these women may require closer monitoring to detect the risk of heart failure earlier."

The researchers said their study is the first to reveal how often heart failure occurs in a large, representative sample of U.S. breast cancer survivors.

Breast cancer survivors are at increased risk for heart failure due to the use of anthracycline and trastuzumab, two of the most effective chemotherapy treatments. These drugs can damage the heart, depending on the amount a patient receives during treatment. Cardioprotective drugs might help prevent this damage, and their effectiveness should be studied, Valina-Toth said.

While the study uncovered a link involving race, breast cancer and heart failure, it didn't prove the existence of a cause-and-effect relationship. Findings presented at medical meetings are considered preliminary until published in a peer-reviewed medical journal.

More information

The U.S. National Heart, Lung, and Blood Institute has more about heart failure.

-- Robert Preidt

SOURCE: American College of Cardiology, news release, March 7, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Pending Upheaval in"The Year of the Great EHR Switch" Shifts Spotlight to e-Health Industry's Best, Black Book Reveals 2013 Top Scoring Vendors
2. Obama MIA On Jim Crow During Black History Month
3. A Few Extra Pounds May Harm Lung Function in Black, Hispanic Kids
4. 2013 Top Black Book Electronic Health Records (EHR) Systems Announced for Ambulatory Physician Groups
5. Top Hospital Electronic Health Records Vendors Rated by Client Satisfaction, Black Book Rankings Announce 2013 Inpatient EHR Leaders
6. Electronic Health Record sellers face make-or-break year of client ultimatums and revolts, reveals 2013 Black Book survey
7. Obese Black Women at Higher Risk for Having Very Large Babies
8. Obesity coverage in black newspapers is mostly negative, MU study finds
9. Breast-Feeding Still Less Common for Black Babies: CDC
10. Cancer Rates Dropping Among Black Americans
11. Blackall Mechanical, Inc. Expands Project Department to Better Serve Customers in North and South Texas
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Black Breast Cancer Survivors Face Higher Heart Failure Risk: Study
(Date:6/27/2016)... Brooklyn, NY (PRWEB) , ... June 27, 2016 ... ... is using cutting edge technology to revolutionize the emergency ambulance transport experience for ... Many are aware of how Uber has disrupted the taxi industry through the ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet ... product that was developed to enhance the health of felines. The formula is all-natural ... two main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews ...
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology: